equitymaster.comFalseFalseVAISHALI PHARMA |
|
Price History |
Price | Rs | 140.1 | | % ch | % | -4.3 |
Mkt Cap | Rs m | 1,501 | | No. of
shares | m | 10.72 |
Vol | '000 | 113.4 | | % ch week | % | -3.2 |
P/E | X | 25.7 | | % ch 1-mth | % | -7.6 |
P/CF | X | 21.1 | | % ch 12-mth | % | -4.1 |
EPS (TTM) | Rs | 5.4 | | 52 week H/L | Rs | 203.6/114.9 |
(As on Mar 28, 2024 (Close)) |
|
Financials |
* Results Consolidated | No. of Months
Year Ending | 12
Mar-19* | 12
Mar-20* | 12
Mar-21* | 12
Mar-22* | 12
Mar-23* |
EQUITY SHARE DATA |
High | Rs | 60 | 49 | NA | 72 | 194 |
Low | Rs | 40 | 24 | NA | 29 | 64 |
Sales per share (Unadj.) | Rs | 113.9 | 57.0 | 51.0 | 71.9 | 66.0 |
Earnings per share (Unadj.) | Rs | 1.1 | 0 | 1.0 | 3.8 | 6.3 |
Diluted earnings per share | Rs | 0.7 | 0.0 | 1.0 | 3.8 | 6.2 |
Cash flow per share (Unadj.) | Rs | 1.5 | 0.4 | 1.4 | 4.2 | 6.7 |
Dividends per share (Unadj.) | Rs | 0 | 0 | 0 | 0 | 0 |
Adj. dividends per share | Rs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Avg Dividend yield | % | 0 | 0 | 0 | 0 | 0 |
Book value per share (Unadj.) | Rs | 32.5 | 20.3 | 21.3 | 25.0 | 31.3 |
Adj. book value per share | Rs | 20.0 | 19.9 | 20.9 | 24.6 | 30.8 |
Shares outstanding (eoy) | m | 6.59 | 10.55 | 10.55 | 10.55 | 10.55 |
Bonus / Rights / Conversions | | 0 | 0 | 0 | 0 | 0 |
Price / Sales ratio | x | 0.4 | 0.6 | 0 | 0.7 | 2.0 |
Avg P/E ratio | x | 46.1 | 1,170.5 | 0 | 13.3 | 20.6 |
P/CF ratio (eoy) | x | 33.5 | 81.3 | 0 | 11.9 | 19.1 |
Price / Book Value ratio | x | 1.5 | 1.8 | 0 | 2.0 | 4.1 |
Dividend payout | % | 0 | 0 | 0 | 0 | 0 |
Avg Mkt Cap | Rs m | 329 | 383 | 0 | 534 | 1,361 |
No. of employees | `000 | NA | NA | NA | NA | NA |
Total wages/salary | Rs m | 21 | 13 | 12 | 14 | 13 |
Avg. sales/employee | Rs Th | 0 | 0 | 0 | 0 | 0 |
Avg. wages/employee | Rs Th | 0 | 0 | 0 | 0 | 0 |
Avg. net profit/employee | Rs Th | 0 | 0 | 0 | 0 | 0 |
INCOME DATA |
Net Sales | Rs m | 751 | 601 | 538 | 758 | 697 |
Other income | Rs m | 20 | 22 | 18 | 18 | 22 |
Total revenues | Rs m | 771 | 623 | 556 | 776 | 719 |
Gross profit | Rs m | 21 | 9 | 26 | 69 | 94 |
Depreciation | Rs m | 3 | 4 | 4 | 5 | 5 |
Interest | Rs m | 27 | 26 | 26 | 25 | 23 |
Profit before tax | Rs m | 11 | 1 | 14 | 57 | 88 |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 |
Tax | Rs m | 4 | 0 | 4 | 17 | 22 |
Profit after tax | Rs m | 7 | 0 | 10 | 40 | 66 |
Gross profit margin | % | 2.8 | 1.5 | 4.9 | 9.1 | 13.5 |
Effective tax rate | % | 37.0 | 58.6 | 25.5 | 29.8 | 25.4 |
Net profit margin | % | 1.0 | 0.1 | 1.9 | 5.3 | 9.5 |
BALANCE SHEET DATA |
Current assets | Rs m | 630 | 612 | 813 | 764 | 727 |
Current liabilities | Rs m | 425 | 404 | 593 | 519 | 321 |
Net working cap to sales | % | 27.3 | 34.6 | 41.0 | 32.3 | 58.3 |
Current ratio | x | 1.5 | 1.5 | 1.4 | 1.5 | 2.3 |
Inventory Days | Days | 21 | 20 | 23 | 16 | 18 |
Debtors Days | Days | 240,236,955 | 285,684,199 | 452,945,946 | 2,816 | 2,809 |
Net fixed assets | Rs m | 57 | 49 | 47 | 50 | 61 |
Share capital | Rs m | 66 | 105 | 105 | 105 | 105 |
"Free" reserves | Rs m | 148 | 108 | 119 | 158 | 224 |
Net worth | Rs m | 214 | 214 | 224 | 264 | 330 |
Long term debt | Rs m | 48 | 41 | 40 | 31 | 52 |
Total assets | Rs m | 686 | 661 | 860 | 815 | 788 |
Interest coverage | x | 1.4 | 1.0 | 1.5 | 3.3 | 4.9 |
Debt to equity ratio | x | 0.2 | 0.2 | 0.2 | 0.1 | 0.2 |
Sales to assets ratio | x | 1.1 | 0.9 | 0.6 | 0.9 | 0.9 |
Return on assets | % | 4.9 | 3.9 | 4.3 | 8.0 | 11.2 |
Return on equity | % | 3.3 | 0.2 | 4.7 | 15.3 | 20.0 |
Return on capital | % | 14.5 | 10.4 | 15.2 | 27.9 | 29.1 |
Exports to sales | % | 18.7 | 21.7 | 16.7 | 18.3 | 25.2 |
Imports to sales | % | 0 | 0 | 0 | 5.2 | 7.8 |
Exports (fob) | Rs m | 140 | 130 | 90 | 138 | 176 |
Imports (cif) | Rs m | 0 | 0 | 0 | 39 | 54 |
Fx inflow | Rs m | 140 | 130 | 90 | 138 | 176 |
Fx outflow | Rs m | 2 | 2 | 0 | 41 | 55 |
Net fx | Rs m | 138 | 128 | 90 | 98 | 121 |
CASH FLOW |
From Operations | Rs m | 43 | 32 | 20 | 13 | 11 |
From Investments | Rs m | -3 | -0 | -1 | -8 | 3 |
From Financial Activity | Rs m | -40 | -31 | -18 | 4 | -17 |
Net Cashflow | Rs m | 0 | 1 | 1 | 9 | -4 |
* Results Consolidated | Source: Company Annual Reports, Regulatory Filings, Equitymaster |
|
Share Holding |
Indian Promoters: | 26.6% |
Foreign collaborators: | 0.0% |
Indian inst/Mut Fund: | 0.0% |
FIIs: | 0.0% |
ADR/GDR: | 0.0% |
Free float: | 73.4% |
Shareholders: | 9,181 |
Pledged promoter(s) holding: | 0.0% |
|
Company Information |
REGD OFF: | 706 To 709 7th Floor Aravali Busines Center, R. C. Patel Road Off Sodawala Lane, Borivali (West), Mumbai - 400092 |
E-MAIL: | investor@vaishalipharma.com / cs@vaishalipharma.com |
WEB: | www.vaishalipharma.com |
TELEPHONE: | 022 42171819 |
FAX: | 022 28928833 |
SECTOR: | PHARMACEUTICALS |
GROUP: | Private sector |
TR AGENT: | Bigshare Services Pvt Ltd, Office No S6-2 6th Floor Pinnacle Business Park, Next to Ahura Centre Mahakali Caves Road, Andheri (E) |
CHM: | Atul Vasani |
COMP SEC: | Akshay Jharkhandi |
YEAR OF INC: | 2008 |
NSE CODE: | 563147895 |
FV (Rs): | 10 |
DIV YIELD (%): | - |